Cite
MLA Citation
Hugo Marcel Vanderstichele et al.. “O4‐11‐02: The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer's disease: For the coalition against major diseases.” Alzheimer's & dementia, vol. 11, n.d., p. P296. http://access.bl.uk/ark:/81055/vdc_100102669785.0x000022